CliniCan: Foundations of Medical Cannabis Science, Standardization, and Clinical Practice
Clinical Cannabis Education for Pharmacists and Healthcare Professionals
Join the International Society of Cannabis Pharmacists for CliniCan Foundations, a live virtual educational program designed to build a strong foundation in the science and clinical application of cannabis and cannabinoid therapies.
Saturday, February 20, 2027
10:00 AM–6:30 PM ET
Live Virtual Program
8.0 ACPE-approved contact hours / 0.8 CEUs for eligible participants
About the Program
CliniCan Foundations brings together experts in cannabinoid science, pharmacology, clinical practice, safety, product quality, documentation, and professional practice for a full day of evidence-based education.
The program is designed for pharmacists and other healthcare professionals who want a stronger understanding of cannabinoid therapy and its application to patient care.
Program Agenda
All times listed in Eastern Time (ET)
10:00 AM | Beyond the Endocannabinoid System: Understanding the Endocannabinoidome
Presented by Codi Peterson, PharmD
11:00 AM | Phytocannabinoid Pharmacology: From Mechanisms to Clinical Effects
Presented by Linda Klumpers, PhD
12:00 PM | Cannabinoids in Clinical Practice: Evaluating the Evidence Across Therapeutic Indications
Presented by Raymond Vellky, PharmD
1:00 PM | Lunch Break
Non-accredited sponsored presentations may be offered during the lunch period and will be clearly identified separately from the accredited educational program.
1:30 PM | Cannabinoid Therapy: From Initiation to Optimization
Presented by Melani Kane, PharmD
2:00 PM | From Evidence to Practice: Clinical Decision-Making in Cannabinoid Therapy
Presented by Melani Kane, PharmD
2:30 PM | Knowledge Check
2:45 PM | Cannabis Contaminants Across the Supply Chain
Presented by Andy Krut, PharmD
3:15 PM | Equipment in Action: From Analytical Testing to the Certificate of Analysis
Presented by Jahan Marcu, PhD
3:45 PM | Break
3:50 PM | Cannabis Quality in Context: Industry Standards and Global Regulatory Frameworks
Presented by Jahan Marcu, PhD
4:50 PM | Knowledge Check
5:05 PM |Standardizing Cannabinoid Documentation Across Clinical Practice
Presented by Christine Roussel, PharmD
5:35 PM |Pharmacists at the Front Line: Advancing Safe and Effective Cannabis Care – International Pharmacist Panel
Moderated By Sangeeta Nathoo, BPharm (Hons)
Panelists: Codi Peterson, PharmD; Raymond Vellky, PharmD; Andy Krut, PharmD; Melani Kane, PharmD; Matthew Soliman, BMedSci MPharm
6:35 PM | Closing Remarks
Registration
Early-bird registration through January 15, 2027
ISCPh Members
Early Bird: $99
Regular: $149
Nonmembers
Early Bird: $249
Regular: $299
Not yet an ISCPh member?
Annual membership is $125. Join ISCPh and receive access to member pricing for CliniCan Foundations, along with member education, professional resources, networking, research opportunities, and other benefits throughout the year.
Learning Objectives
- Differentiate the classical endocannabinoid system from the expanded endocannabinoidome, including its major components and roles in homeostasis.
- Evaluate the evidence supporting the Clinical Endocannabinoid Deficiency hypothesis.
- Analyze the pharmacodynamic properties and clinical considerations of major phytocannabinoids and commonly used cannabinoid formulations.
- Evaluate clinically relevant cannabinoid drug interactions, drug-disease interactions, and evidence supporting the entourage hypothesis.
- Evaluate the evidence supporting cannabinoid therapy for symptoms and conditions commonly encountered in clinical practice.
- Assess the appropriateness of cannabinoid therapy based on patient-specific risks, contraindications, precautions, and applicable medical cannabis program requirements.
- Differentiate cannabinoid- and formulation-specific adverse effects and their implications for therapeutic selection.
- Apply patient-specific factors to optimize cannabinoid selection, formulation, dosing, and follow-up.
- Design individualized cannabinoid treatment strategies for complex patient presentations using conservative dosing, titration, monitoring, and therapeutic optimization principles.
- Identify common contaminants encountered throughout the medical cannabis supply chain and strategies used to minimize contamination.
- Interpret cannabis certificates of analysis using relevant analytical methods, potency results, and contaminant testing data.
- Compare regulatory frameworks governing hemp and medical cannabis across United States and international jurisdictions.
- Describe the role of standardized cannabis medication history and electronic health record documentation in supporting clinical assessment, medication reconciliation, and continuity of care.
- Identify professional roles, practice opportunities, and evidence-based resources that support pharmacist involvement in medical cannabis care.
Faculty and Panel
Our esteemed and carefully selected faculty include:
Codi Peterson, PharmD
Linda Klumpers, PhD
Raymond Vellky, PharmD
Melani Kane, PharmD
Andy Krut, PharmD
Jahan Marcu, PhD
Christine Roussel, PharmD, BCOP, BCSCP
Sangeeta Nathoo, BPharm (Hons)
Matthew Soliman, BMedSci MPharm
Continuing Pharmacy Education
Activity Type: Knowledge
Target Audience: Pharmacists
Format: Live virtual webinar with on-demand access
CPE Credit: 8.0 contact hours / 0.8 CEUs
Live Activity Date: Saturday, February 20, 2027
Time: 10:00 AM–6:30 PM ET
Initial Release Date: February 20, 2027
Expiration Date: February 20, 2030
Live UAN: 0226-0000-26-009-L99-P
Home Study UAN: 0226-0000-26-009-H99-P
Accredited Provider
Alpha Zeta Omega National Pharmaceutical Fraternity Philadelphia Alumni Chapter is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for Successful Completion
Participants must:
- Register for the activity.
- Complete the live webinar or on-demand activity in full.
- Complete any required learning assessment and program evaluation.
- Submit their NABP e-Profile ID and month/day of birth for CPE Monitor reporting.
- Meet all provider requirements to receive CPE credit.
Commercial Support
No commercial support has been received for this activity.
Questions?
For questions about CliniCan Foundations, contact the International Society of Cannabis Pharmacists.
